Salam Healthier Future Assurance (SHIFA) - Signature

SHIFA Signature is Sun Life Syariah’s premium-tier comprehensive health takaful — the higher shelf above SHIFA Essential and a step up from Sun Healthcare Solution Syariah in coverage ceiling and geographic reach. Unlike SHIFA Essential, which is a CI-triggered reimbursement product limited to four killer diseases, SHIFA Signature is a general inpatient-and-surgery health product covering all illnesses, with seven plan tiers from Indo 1 (Rp 4 billion annual limit) up to Worldwide (Rp 15 billion annual limit). Every plan adds a one-time Limit Booster on top of the annual limit, taking the lifetime ceiling on a single severe episode up to Rp 35 billion for the Worldwide plan. The product runs on Akad Tabarru’ and Akad Wakalah bil Ujrah, is renewable to insured age 100, covers global treatment including the United States on the top three tiers, and rewards claim-free policyholders with a No-Claim Benefit discount of up to 15% on next-year contribution. In one line: the syariah answer for affluent Indonesian families whose protection question is no longer “will the bill be covered” but “what happens if my child needs cancer treatment in Houston.”

---

The RIPLAY ships with one published sample case — male age 40, Plan Indo 1, annual contribution Rp 10,316,000. The block below decodes that case plus the cross-plan ceilings agents will actually quote in the field.

Critical reading on Limit Booster: the brochure marketing leans on the headline “up to Rp 35 billion” (Worldwide), but Limit Booster is once per insured lifetime, single shot, and only triggered after the annual ceiling is fully exhausted in that policy year. It is a catastrophic-event backstop, not an annual benefit. Agents must explain this; surfacing only the Rp 35B figure is mis-positioning.

Critical reading on the sample contribution: Rp 10,316,000 is for entry-tier Indo 1 at male 40. The Worldwide plan, female 40, or insured ages 50+, 60+ will be materially higher. Without published age-tier tables, agents must quote only via the actual SPAJ quoting tool — not by extrapolating from the brochure.

---

Sweet Spot — Lead with SHIFA Signature

• Muslim mass-affluent and affluent households, household income Rp 60M+/month for entry-tier (Indo 1/Indo 2), Rp 120M+/month for Asia tiers, Rp 250M+/month for Asia Plus or Worldwide
• Age 30–50, head of family, dependants (spouse + 1–3 children), already has BPJS Kesehatan and ideally an employer health card — looking for the genuine private-hospital safety layer that activates without out-of-pocket shock
• Cross-border footprint: dual-country lifestyle (Jakarta–Kuala Lumpur, Jakarta–Singapore, Surabaya–Penang), children studying overseas, business travel through Asia, or family that flies to Penang/Singapore/Bangkok for medical second opinions
• Religiously motivated to use syariah financial products and would actively decline a conventional health policy at parity feature
• Comfortable explaining and accepting Akad Tabarru’ / Akad Wakalah bil Ujrah — does not need over-explanation but does want transparency on the Ujrah rate
• Risk-averse personality on health — willing to pay a premium contribution for the catastrophic-coverage headroom rather than self-insuring with savings/gold/sukuk

Borderline Fit — Qualify carefully before proceeding

• Mass-affluent customer between Rp 30M–60M/month household income — SHIFA Essential, Sun Healthcare Solution Syariah, or AlliSya Flexi Medical Syariah may serve them better at the contribution level. Run the affordability test at insured age 50 and age 60 before writing — annual contributions on Signature escalate with age and Indonesian medical inflation
• Customer who travels heavily to Singapore, Hong Kong, or Japan but is being shown Indo 1/Indo 2 — those plans reimburse only 15% in those three jurisdictions. Push them up to Asia Plus 1/2 or Worldwide, or do not write
• Customer with elderly insured (60–70) — entry is allowed up to insured age 70, but the contribution loading will be heavy and the runway to age-100 cap is short
• Customer already holding Sun Healthcare Solution Syariah or another comprehensive syariah health policy — duplication risk; the coordination-of-benefits clause means the second policy mostly pays the gap, not the headline limit
• Customer who hesitates on the Wakalah fee disclosure (47–49% Ujrah) — engage the objection in Section 7 before writing; a customer who signs reluctantly on the Ujrah point is a future complaint

Do Not Pitch

• Customers without basic health coverage at all (no BPJS, no employer card) — sell them BPJS Class 1 first; Signature is the wrong entry point
• Households where premium continuity is at risk (income volatility, recent business stress) — annual contribution escalation plus the 60-day grace lapse rule makes this unforgiving
• Customers expecting maternity, dental, or routine outpatient coverage — explicitly excluded; outpatient is restricted to the pre-/post-hospitalisation window only
• Customers with pre-existing conditions in any of the 21 Penyakit Khusus categories listed in the RIPLAY (hypertension, diabetes, kidney disease, all cancers, spinal issues, etc.) — the 12-month exclusion applies from policy inception or reinstatement; high mis-sell and claim-denial risk
• Customers who explicitly want a CI lump-sum on diagnosis — wrong product; redirect to AlliSya CI Hasanah or pair Signature with a separate CI takaful policy
• Customers whose syariah preference is loose — they are likely better served by conventional comprehensive products at a lower Ujrah-equivalent cost; do not pitch Signature on syariah branding alone

---

Rule of thumb: if the prospect’s first sentence contains “berobat ke luar negeri” (treatment abroad), “anak sekolah di Singapore/US” (child studying overseas), “syariah dong” (syariah only), and household income clearly clears Rp 100M+/month, SHIFA Signature is in the conversation — most likely an Asia Plus or Worldwide tier. If their first sentence contains “yang murah aja” (just the cheap one), “BPJS kayaknya cukup” (BPJS is probably enough), or “saya cuma butuh untuk kalau kena kanker” (I just need cover for cancer), Signature is the wrong door — redirect.

---

The Indonesian agency health category catalogues 33 products at 100% PDF coverage as of 2026-05-20, but the cross-product quantitative threshold has not been met across all comparison metrics. Comparisons below are qualitative against the documented peer set, with strongest direct cross-references to two sibling products in the same insurer (Sun Healthcare Solution Syariah and SHIFA Essential) and the most-comparable Allianz AlliSya product.

---

Opening — establish the right frame

“Most syariah health products in the market are designed for the middle income — they work, but they cap out exactly where the bills get serious. SHIFA Signature is designed for families whose protection question isn’t ‘will the hospital bill be covered’ — it’s ‘what happens if my child needs specialist treatment in Singapore, or surgery in the US’. That’s a different conversation, and it needs a different product.”

“Kebanyakan produk kesehatan syariah di pasar didesain untuk kelas menengah — fungsinya jalan, tapi batasnya habis tepat saat tagihannya mulai serius. SHIFA Signature didesain untuk keluarga yang pertanyaannya bukan lagi ‘tagihan rumah sakitnya ke-cover nggak’ — tapi ‘kalau anak saya butuh perawatan spesialis di Singapura, atau operasi di Amerika, gimana’. Itu pembicaraan yang beda, dan butuh produk yang beda.”

The structural value prop (annual limit + Limit Booster)

“Two things make this product different. First — your annual limit on the entry plan is Rp 4 billion, and on the top plan it’s Rp 15 billion. That resets every year. Second — if you ever have a catastrophic year and burn through that annual limit, the Limit Booster kicks in once in your lifetime and gives you up to Rp 35 billion of extra capacity. Think of it as your one-shot safety net for the worst-case medical event.”

“Ada dua hal yang bikin produk ini beda. Pertama — batas tahunan Anda di plan paling dasar itu Rp 4 miliar, dan di plan paling atas Rp 15 miliar. Ini reset setiap tahun. Kedua — kalau Anda mengalami tahun yang sangat berat dan limit tahunannya habis, Limit Booster aktif sekali seumur hidup dan menambah kapasitas sampai Rp 35 miliar. Anggap saja ini jaring pengaman sekali tembak untuk skenario kesehatan paling buruk.”

The global coverage pitch (Asia Plus / Worldwide)

“If your family travels, your children study overseas, or you take serious medical decisions to Singapore or Penang — the Worldwide plan covers your treatment anywhere in the world at 100%, including the United States. That’s a feature you will not find in most syariah health products in this market. Asia Plus is the step below — full coverage across Asia including Hong Kong, Singapore, and Japan, but the US drops to 30% reimbursement.”

“Kalau keluarga Anda sering bepergian, anak-anak studi di luar negeri, atau Anda biasa ambil keputusan medis serius di Singapura atau Penang — plan Worldwide ini cover perawatan Anda di mana saja di dunia 100%, termasuk Amerika Serikat. Ini fitur yang tidak akan Anda temukan di kebanyakan produk kesehatan syariah di pasar ini. Asia Plus tingkat di bawahnya — cover penuh seluruh Asia termasuk Hong Kong, Singapura, dan Jepang, tapi untuk Amerika turun ke 30% penggantian.”

The Tabarru’ / Wakalah disclosure (lead with it, do not bury)

“Before we go further — let me explain how the structure works, because it matters. SHIFA Signature uses two Islamic contracts. Akad Tabarru’ means your contribution joins a shared risk pool with other participants; claims are paid from that pool, not from Sun Life’s own balance sheet. Akad Wakalah bil Ujrah means Sun Life acts as the wakil — the appointed manager — of that pool, and charges a transparent fee for that service. On your plan, that fee is around 46–49% of your contribution. The rest — 51–54% — enters the Tabarru’ pool. This is disclosed in writing in the RIPLAY; I am not hiding it.”

“Sebelum kita lanjut — saya jelaskan dulu strukturnya, karena ini penting. SHIFA Signature pakai dua akad Islam. Akad Tabarru’ artinya kontribusi Anda masuk ke dana bersama dengan peserta lain; klaim dibayarkan dari dana itu, bukan dari neraca Sun Life. Akad Wakalah bil Ujrah artinya Sun Life jadi wakil — pengelola yang ditunjuk — untuk dana itu, dan mengambil fee yang transparan untuk jasa pengelolaan. Di plan Anda, fee itu sekitar 46–49% dari kontribusi. Sisanya — 51–54% — masuk ke dana Tabarru’. Ini diungkapkan tertulis di RIPLAY; saya tidak menyembunyikan.”

The No-Claim Benefit narrative

“There is one more thing built into Signature that I want you to know about. If you don’t claim for one year, you get a 5% discount on next year’s contribution. Two years claim-free, 10%. Three years or more, 15%. So in a sense, your discipline and good health are rewarded. The discount resets if you do file a claim — that’s fair, because that year the pool covered you.”

“Ada satu hal lagi yang built-in di Signature yang ingin saya sampaikan. Kalau Anda nggak klaim selama satu tahun, Anda dapat diskon 5% untuk kontribusi tahun berikutnya. Dua tahun tanpa klaim, 10%. Tiga tahun atau lebih, 15%. Jadi disiplin dan kesehatan Anda dihargai. Diskon-nya reset kalau Anda klaim — itu fair, karena tahun itu Anda sudah ditanggung dana bersama.”

The close (against Sun Healthcare Solution as the obvious step-down)

“If the contribution at this tier turns out to be a stretch, we don’t force the fit. Sun Healthcare Solution Syariah from the same insurer covers you at the mass-affluent shelf with the auto-increasing annual limit feature — a different mechanic but solid coverage for the Indonesia and regional context. SHIFA Signature is the right product when global reach and Rp 4–15 billion annual headroom genuinely match your situation. Want me to run the actual quote for your age band on both, so you can compare side by side?”

“Kalau kontribusi di tier ini terasa berat, kita nggak paksakan. Sun Healthcare Solution Syariah dari penanggung yang sama cover Anda di kelas mass-affluent dengan fitur batas tahunan yang naik otomatis — mekanik beda tapi coverage-nya solid untuk konteks Indonesia dan regional. SHIFA Signature itu produk yang tepat saat coverage global dan kapasitas Rp 4–15 miliar per tahun memang sesuai situasi Anda. Mau saya bandingkan ilustrasi kontribusi sebenarnya di usia Anda untuk keduanya, supaya bisa lihat berdampingan?”

—

1. “Is it really halal — what about the risk that the Dana Tabarru’ runs into deficit?”

Customer “Beneran halal nggak sih ini — kalau Dana Tabarru’-nya defisit gimana?”

Don't say “It’s halal, just trust me — there’s no risk.” — dismisses a genuine theological question.

Don't say “Halal kok, percaya aja — nggak ada risikonya.”

Do say “Good question — and I want to answer it directly. SHIFA Signature uses Akad Tabarru’ (mutual risk-sharing donation) and Akad Wakalah bil Ujrah (Sun Life as your appointed manager for a disclosed fee). The deficit scenario is real and real takaful products are designed for it: if claims exceed contributions plus reserves in a given year, Sun Life provides a Qardh — an interest-free loan — to cover the shortfall. That Qardh is then repaid from future Tabarru’ surpluses before fresh surplus sharing resumes. So the pool is protected, but you should know the structural fact: a deficit shifts the load to Sun Life’s capacity to extend Qardh. Sun Life Syariah’s RBC is 220% as of September 2025 — well above the 120% regulatory floor — so the buffer is healthy today. But I won’t tell you the structure is risk-free. It isn’t. It’s a takaful structure, and you should know exactly how it works.”

Do say “Pertanyaan bagus — saya jawab langsung. SHIFA Signature pakai Akad Tabarru’ (saling tolong-menolong, kontribusi sebagai hibah ke dana bersama) dan Akad Wakalah bil Ujrah (Sun Life sebagai wakil pengelola, dengan fee yang transparan). Skenario defisit memang ada dan produk takaful yang benar memang didesain untuk itu: kalau klaim di satu periode melebihi kontribusi plus cadangan, Sun Life kasih Qardh — pinjaman tanpa bunga — untuk menutup. Qardh-nya nanti dilunasi dari surplus Tabarru’ tahun-tahun berikutnya sebelum surplus baru dibagikan. Jadi dana-nya terlindungi, tapi Anda perlu tahu faktanya: defisit menggeser beban ke kapasitas Sun Life untuk kasih Qardh. RBC Syariah Sun Life saat ini 220% per September 2025 — jauh di atas batas minimum 120% — jadi buffer-nya sehat. Tapi saya tidak akan bilang strukturnya bebas risiko. Tidak. Ini struktur takaful, dan Anda berhak tahu persis cara kerjanya.”

—

2. “Why not just BSI’s takaful — they’re the syariah-bank brand?”

Customer “Kenapa nggak BSI takaful aja — kan brand bank syariah?”

Don't say “BSI products are inferior.” — alienates the customer who likely banks at BSI.

Don't say “Produk BSI kurang bagus.”

Do say “BSI Asuransi Syariah is a legitimate option, and many of my clients hold BSI products for general syariah health coverage at the mass-market tier. Where SHIFA Signature is different is the ceiling: annual limit Rp 4–15 billion, plus a one-time Limit Booster of up to Rp 35 billion, plus Worldwide coverage including the US at 100% on the top plan. If your need is general hospitalisation at Indonesian private hospitals, BSI may serve you fine and at lower contribution. If your need is the catastrophic-scenario layer — global treatment, surgery overseas, multi-year cancer therapy — that’s where Signature is structurally built. They serve different purposes; for some customers, both make sense.”

Do say “BSI Asuransi Syariah itu opsi yang sah, dan banyak klien saya pegang produk BSI untuk coverage kesehatan syariah umum di tingkat mass-market. Bedanya SHIFA Signature ada di plafonnya: batas tahunan Rp 4–15 miliar, plus Limit Booster sekali seumur hidup sampai Rp 35 miliar, plus coverage Worldwide termasuk Amerika 100% di plan teratas. Kalau kebutuhan Anda rawat inap umum di RS swasta Indonesia, BSI mungkin cukup dan kontribusinya lebih ringan. Tapi kalau kebutuhan Anda lapisan untuk skenario katastrofik — perawatan global, operasi di luar negeri, terapi kanker multi-tahun — di situ Signature memang dibangun strukturnya. Beda tujuan; untuk sebagian nasabah, dua-duanya masuk akal.”

—

3. “The premium is too high vs Essential — why not just take Essential and save money?”

Customer “Premi-nya kemahalan dibanding Essential — kenapa nggak ambil Essential aja yang lebih hemat?”

Don't say “Essential isn’t enough — you need Signature.” — fights the customer’s budget question instead of clarifying the product difference.

Don't say “Essential nggak cukup — Anda harus Signature.”

Do say “These are not two grades of the same product — they’re two different products. SHIFA Essential is critical-illness-triggered reimbursement: it activates only for stroke, cancer, cardiovascular, or kidney failure, and pays bills up to Rp 500M–2B per condition per year. SHIFA Signature is general comprehensive health: it activates for any covered illness, and the annual limit is Rp 4–15 billion. If you’re worried specifically about the four killer diseases and your other health risk is manageable, Essential is the right product and the lower cost is rational. If you want comprehensive cover — appendicitis, road accidents, surgery for anything covered by the policy — then you need Signature, not Essential. Let me ask: what’s the actual scenario you’re trying to protect against?”

Do say “Dua produk ini bukan dua kelas dari produk yang sama — beda produk. SHIFA Essential itu reimbursement yang dipicu penyakit kritis: aktif hanya untuk stroke, kanker, jantung, atau gagal ginjal, dan bayar tagihan sampai Rp 500 juta–2 miliar per kondisi per tahun. SHIFA Signature itu kesehatan komprehensif: aktif untuk semua penyakit yang ditanggung polis, dan batas tahunannya Rp 4–15 miliar. Kalau yang Anda khawatirkan khusus empat penyakit pembunuh itu dan risiko kesehatan lainnya manageable, Essential memang produk yang tepat dan hemat itu rasional. Kalau Anda mau coverage komprehensif — usus buntu, kecelakaan, operasi apapun yang masuk polis — Anda butuh Signature, bukan Essential. Boleh saya tanya: skenario sebenarnya yang ingin Anda lindungi itu apa?”

—

4. “I’d rather save and pay cash for medical bills — gold and sukuk give me liquidity I can actually use.”

Customer “Mendingan saya nabung sendiri buat biaya medis — emas dan sukuk kasih saya likuiditas yang beneran bisa dipakai.”

Don't say “Your savings won’t be enough.” — patronising, and probably wrong about a specific affluent customer.

Don't say “Tabungan Anda nggak akan cukup.”

Do say “I respect that — self-insuring with liquid syariah-compliant assets is a real strategy and it works at certain wealth levels. Let me reframe the question. If you’re comfortable that your gold and sukuk position can absorb a Rp 5–10 billion bill for a cancer treatment that runs across multiple countries and three years, then self-insure. But ask yourself: when that bill arrives, do you really want to liquidate your sukuk allocation at whatever price the market gives you that month? Or do you want a structure where the bill is paid first and your sukuk stays intact, compounding? Signature is not a savings substitute — it’s a liquidity-protection mechanism. The Tabarru’ pool absorbs the bill so your invested capital stays invested.”

Do say “Saya hormati pemikirannya — self-insure pakai aset syariah likuid itu strategi yang nyata dan jalan di level kekayaan tertentu. Tapi izinkan saya reframe. Kalau Anda yakin posisi emas dan sukuk Anda bisa nyerap tagihan Rp 5–10 miliar untuk perawatan kanker lintas negara selama tiga tahun, ya silakan self-insure. Tapi tanya pada diri sendiri: pas tagihan itu datang, apakah Anda benar-benar mau cairkan alokasi sukuk Anda di harga pasar bulan itu? Atau Anda lebih suka struktur di mana tagihannya dibayar duluan dan sukuk Anda tetap utuh, berbunga compound? Signature bukan pengganti tabungan — ini mekanisme proteksi likuiditas. Dana Tabarru’ yang nyerap tagihan, supaya modal Anda yang sudah diinvestasikan tetap di tempat dan terus tumbuh.”

—

5. “What’s the actual difference vs Healthcare Solution Syariah — they sound the same?”

Customer “Sebenarnya bedanya apa sih sama Healthcare Solution Syariah — kedengarannya mirip?”

Don't say “Signature is just the better one.” — vague and dismissive; the customer is asking a sharp question.

Don't say “Signature itu yang lebih bagus.”

Do say “They’re both comprehensive syariah health products from Sun Life, and they overlap. Three real differences: One — Signature’s annual limit floor is Rp 4 billion; Sun Healthcare Solution starts at Rp 250 million (Opal) and tops out at Rp 10 billion. Signature is positioned higher. Two — Signature has the Worldwide tier with US coverage at 100%; Sun Healthcare Solution caps regionally at Indonesia + Malaysia + Singapore (Safir tier). Three — Sun Healthcare Solution has a mandatory Sun Medical Saver co-payment of Rp 8M–20M per hospitalisation episode; Signature today does not have an explicit per-episode co-pay in the published benefit table. There’s also a contribution gap — Signature entry is roughly twice Sun Healthcare Solution at the same age. For an Indonesia-focused mass-affluent customer, Sun Healthcare Solution is often the right pick. For a globally-mobile affluent customer, Signature is. If you’re not sure which describes you, I’d rather we work through that question than push a tier.”

Do say “Dua-duanya produk kesehatan syariah komprehensif dari Sun Life, dan memang overlap. Tiga perbedaan riilnya: Pertama — batas tahunan Signature mulai dari Rp 4 miliar; Sun Healthcare Solution mulai dari Rp 250 juta (Opal) sampai Rp 10 miliar (Safir). Signature posisinya lebih tinggi. Kedua — Signature punya tier Worldwide dengan coverage Amerika 100%; Sun Healthcare Solution batas regionalnya Indonesia + Malaysia + Singapura (Safir). Ketiga — Sun Healthcare Solution wajib pakai Sun Medical Saver, co-payment Rp 8–20 juta per episode rawat inap; Signature di tabel manfaat saat ini belum ada co-payment per-episode yang eksplisit. Ada juga selisih kontribusi — Signature kira-kira 2x Sun Healthcare Solution di usia yang sama. Untuk nasabah mass-affluent yang fokus Indonesia, Sun Healthcare Solution sering jadi pilihan yang tepat. Untuk nasabah affluent yang mobile global, Signature jawabannya. Kalau belum yakin mana yang gambarin Anda, mendingan kita jalanin diskusinya bareng — saya nggak dorong tier sembarangan.”

—

These are the issues most likely to generate an OJK complaint or post-sale dispute in the post-POJK-36/2025 environment. Build the agent compliance pack around avoiding all seven.

1. POJK 36/2025 co-payment regime — applies to all health products including syariah. Effective January 2026, POJK 36/2025 imposes a mandatory co-payment / Risiko Sendiri regime on health insurance and takaful. The SHIFA Signature RIPLAY currently published (Agency_v.1/SLFI/2026) does not feature an explicit Sun-Medical-Saver-style per-episode co-payment in the benefit table. Two implications: (a) the only de facto co-pay mechanism today is the room-upgrade prorata clause (if the participant upgrades above the plan room rate, all benefit items are prorated from day one, not just the room) — this MUST be explained at SPAJ stage; (b) a regulatory update to add an explicit Signature co-payment is plausible within 2026 and agents should monitor for a RIPLAY refresh. Do not represent the current absence of an explicit co-pay as a permanent feature. Verify the active RIPLAY version at every fresh sale.

2. Tabarru’ fund deficit risk disclosure. The Dana Tabarru’ is a finite risk-sharing pool. If claims plus reinsurance costs plus technical-reserve growth exceed contributions in a given period, the fund goes into deficit and Sun Life advances a Qardh (interest-free loan) to cover. Customers must be told: (a) the fund can run a deficit, (b) in such a case, future surplus-sharing pauses until the Qardh is repaid, and © the fund’s resilience depends partly on Sun Life’s willingness and capacity to extend Qardh. This is structurally different from conventional insurance where the insurer’s own balance sheet is the primary backstop. Bury this and you set up a future complaint.

3. Wakalah bil Ujrah fee transparency. Per-plan Ujrah ranges from 46% to 49% of contribution — at the high end of the syariah health market. POJK syariah insurance regulations require the Tabarru’/Ujrah split to be disclosed in writing in the RIPLAY and verbally to the prospective participant before SPAJ signature. Agents MUST state the applicable percentage for the plan being sold (“for Plan Worldwide, your Ujrah is 49% of contribution, your Tabarru’ contribution is 51%”) and confirm customer understanding. Vague phrasing like “ada biaya pengelolaan” without a number is a compliance violation.

4. Akad clarity at SPAJ stage. The participant must explicitly affirm both akads at SPAJ signature: Akad Tabarru’ (their contribution is a donation to the risk-sharing pool, not a payment for risk-transfer to Sun Life) and Akad Wakalah bil Ujrah (they are appointing Sun Life as wakil to manage the pool, in exchange for Ujrah). Do not let the customer treat SPAJ as a generic insurance application. The two akads are the basis on which the product is sharia-compliant; missing or unclear akad affirmation can be raised by Dewan Pengawas Syariah and by the participant in dispute.

5. Premium-tier mis-positioning — Signature pitched to customers who fit Essential or Sun Healthcare Solution. This is the highest-friction mis-selling risk in this product. SHIFA Signature is a premium-tier comprehensive health product; its entry contribution at male age 40 is Rp 10.3M/year and tops Rp 20–40M/year at higher tiers and ages. Pitching Signature to a customer whose actual budget and risk fit SHIFA Essential (CI reimbursement) or Sun Healthcare Solution Syariah (mass-affluent comprehensive) is structural mis-selling — driven by the higher commission, not the customer need. Use the Decision Framework in Section 4 as a written documentation trail; if a customer is being placed in Signature when their household income, travel pattern, or stated need doesn’t justify it, document the override rationale.

6. Global / USA coverage actuarial disclosure. The Worldwide plan’s 100% reimbursement for treatment in the United States is a strong feature, but the actuarial implications must be disclosed: (a) US medical inflation runs materially higher than Indonesian medical inflation and the annual contribution review can move sharply; (b) Sun Life can change the contribution with 30 business days written notice; © the Rp 15B annual limit, while large by Indonesian standards, can be consumed quickly by US oncology, transplant, or NICU treatment — at which point the once-lifetime Limit Booster (up to Rp 35B aggregate ceiling) is the only further headroom. Do not let the customer assume the Worldwide plan is unlimited in any economic sense.

7. Limit Booster — one-shot lifetime mechanism, not annual. The brochure headline “up to Rp 35 billion” refers to the lifetime cumulative cap including Limit Booster, used once per insured lifetime, and only triggered after the annual ceiling is fully exhausted in a single policy year. It is not a Rp 35B annual fund. Agents who quote “Rp 35 billion” without unpacking the one-shot mechanic are mis-positioning the product. Always pair the headline with: “this is your once-lifetime catastrophic-event backstop, not a yearly figure.”

---

---

1. Build a Signature vs AlliSya Flexi Medical Syariah head-to-head battlecard (Week 1-2). SHIFA Signature is positioned in the same affluent syariah-comprehensive-health shelf where Allianz AlliSya competes. Legacy Income agents will encounter Signature in cross-comparison conversations. Build a one-page battlecard covering: annual limit ranges, global reach (the genuine Signature advantage at the Worldwide tier including US 100%), renewal ceiling (Signature 100 vs AlliSya 80), Ujrah rate at parity tier, and contribution comparison. Highlight where AlliSya legitimately wins — do not run a partisan piece, run an honest one. Target distribution: all active Legacy Income syariah-trained agents by end of week 2.

2. Run a Tabarru’ deficit / Qardh disclosure training session (Week 2). Section 8 item #2 is the syariah-specific compliance disclosure most likely to be skipped in the field. Run a 45-minute training where agents practise saying out loud: “Dana Tabarru’ bisa defisit; Sun Life kasih Qardh tanpa bunga; tapi struktur ini bukan bebas risiko.” Audio-record the exercise; review three agents’ phrasing for natural delivery without over-explanation. Goal: every agent who pitches any syariah comprehensive health product (Signature, Healthcare Solution, AlliSya) can deliver this disclosure unprompted within 30 seconds.

3. Develop a structured “tier-fit interview” before any Signature recommendation (Week 1). The premium-tier mis-positioning risk (Section 8 item #5) is real. Build a 7-question intake form agents complete before recommending Signature, covering: household monthly income, primary residence country, travel pattern (Asia / Asia Plus / Worldwide), employer health card status, BPJS status, existing private health policies, and explicit syariah preference rationale. Customers whose answers don’t justify Signature must be redirected to Sun Healthcare Solution Syariah or SHIFA Essential per the Decision Framework. File the intake form with every signed SPAJ.

4. Prepare cross-border-mobility prospect targeting list (Week 2-3). The Asia Plus and Worldwide tiers of Signature are differentiators where Legacy Income’s broader portfolio likely cannot match Signature on syariah-comprehensive global terms. Build a list of Legacy Income contacts who: (a) have signalled global mobility (overseas study, multi-country residency, business travel), (b) have signalled syariah preference, and © sit at affluent income tiers. For these contacts, develop a defensive script — Signature is a real competitive product and outreach from Sun Life Syariah agency offices is likely. Position Allianz alternatives honestly, and where Signature is genuinely the right fit for the prospect’s mobility profile, do not pretend otherwise.

5. Monitor for the next Signature RIPLAY refresh (POJK 36/2025 co-payment update) (Week 3-4). Section 8 item #1 flags the most likely product change in 2026: a formal Sun-Medical-Saver-equivalent co-payment clause added to Signature to align with POJK 36/2025 effective January 2026. Set a calendar reminder for monthly check of the Sun Life Indonesia agency-syariah product page (https://www.sunlife.co.id/id/syariah/agency-syariah/health-protection/shifa-signature/). When the RIPLAY version changes from Agency_v.1/SLFI/2026, trigger a refresh of this brief and re-run agent training on the updated co-payment disclosure. Customers written between now and the refresh point may sit under a transitional regime — confirm policy terms with Sun Life agency support before quoting.

---